Cocrystal Pharma (COCP) Short-term Investments (2017 - 2026)
Cocrystal Pharma (COCP) reported Short-term Investments of $75000.0 for Q1 2026, little changed on a YoY basis from $75000.0 in Q1 2025, and little changed sequentially from $75000.0 in Q4 2025.
Cocrystal Pharma (COCP) Short-term Investments (2017 - 2026) Analysis & Trends
Cocrystal Pharma (COCP) has 10 years of Short-term Investments data on file, last reported at $75000.0 in Q1 2026.
- For the quarter ending Q1 2026, Short-term Investments changed 0.0% year-over-year to $75000.0; the trailing twelve-month figure through Mar 2026 stood at $75000.0 (changed 0.0% YoY), and the FY2025 full-year result was $75000.0, changed 0.0% from the prior year.
- Short-term Investments was little changed at $75000.0 in Q1 2026, from $75000.0 in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $75000.0 in Q2 2022 to a low of $75000.0 in Q2 2022.
- A 5-year average of $75000.0 and a median of $75000.0 in 2022 frame the typical range for Short-term Investments.
- Across the five-year window, Short-term Investments jumped 50.0% in 2022 and changed 0.0% in 2023, its largest moves.
- Tracing COCP's Short-term Investments over 5 years: stood at $75000.0 in 2022, then changed by 0.0% to $75000.0 in 2023, then changed by 0.0% to $75000.0 in 2024, then changed by 0.0% to $75000.0 in 2025, then changed by 0.0% to $75000.0 in 2026.
- Business Quant data shows COCP's Short-term Investments at $75000.0 in Q1 2026, $75000.0 in Q4 2025, and $75000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 75,000.00 |
| Dec 31, 2025 | 75,000.00 |
| Sep 30, 2025 | 75,000.00 |
| Jun 30, 2025 | 75,000.00 |
| Mar 31, 2025 | 75,000.00 |
| Dec 31, 2024 | 75,000.00 |
| Sep 30, 2024 | 75,000.00 |
| Jun 30, 2024 | 75,000.00 |
| Mar 31, 2024 | 75,000.00 |
| Dec 31, 2023 | 75,000.00 |
| Sep 30, 2023 | 75,000.00 |
| Jun 30, 2023 | 75,000.00 |
| Mar 31, 2023 | 75,000.00 |
| Dec 31, 2022 | 75,000.00 |
| Sep 30, 2022 | 75,000.00 |
| Jun 30, 2022 | 75,000.00 |
| Dec 31, 2021 | 50,000.00 |
| Mar 31, 2020 | 50,000.00 |
| Dec 31, 2019 | 50,000.00 |
| Sep 30, 2019 | 50,000.00 |